Petros Fessas

1.4k total citations
14 papers, 529 citations indexed

About

Petros Fessas is a scholar working on Oncology, Hepatology and Cancer Research. According to data from OpenAlex, Petros Fessas has authored 14 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Hepatology and 4 papers in Cancer Research. Recurrent topics in Petros Fessas's work include Cancer Immunotherapy and Biomarkers (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and CAR-T cell therapy research (2 papers). Petros Fessas is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and CAR-T cell therapy research (2 papers). Petros Fessas collaborates with scholars based in United Kingdom, Italy and Japan. Petros Fessas's co-authors include Hassal Lee, Shinji Ikemizu, Tobias Janowitz, David J. Pinato, Ching Ngar Wong, Francesco Mauri, Rohini Sharma, Thomas U. Marron, Gonzalo Sapisochín and Mark Thursz and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Oncogene.

In The Last Decade

Petros Fessas

13 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petros Fessas United Kingdom 8 341 168 141 133 91 14 529
Chiara Spoto Italy 10 279 0.8× 117 0.7× 155 1.1× 109 0.8× 131 1.4× 13 584
Vito Longo Italy 12 284 0.8× 82 0.5× 95 0.7× 128 1.0× 127 1.4× 29 487
Tongguo Si China 13 153 0.4× 126 0.8× 78 0.6× 146 1.1× 75 0.8× 29 405
Claudia Angela Maria Fulgenzi United Kingdom 12 226 0.7× 166 1.0× 60 0.4× 85 0.6× 82 0.9× 47 416
Imane El Dika United States 13 214 0.6× 178 1.1× 75 0.5× 109 0.8× 207 2.3× 30 573
Antonio Gnoni Italy 7 162 0.5× 99 0.6× 74 0.5× 76 0.6× 124 1.4× 9 372
Giulia Orsi Italy 12 220 0.6× 89 0.5× 38 0.3× 148 1.1× 171 1.9× 34 514
Gataree Ngarmchamnanrith United States 14 379 1.1× 63 0.4× 222 1.6× 229 1.7× 232 2.5× 26 651
Chuyu Jing China 13 212 0.6× 89 0.5× 61 0.4× 79 0.6× 107 1.2× 23 432
Bernadette Reyna Asuncion United States 9 425 1.2× 44 0.3× 180 1.3× 301 2.3× 147 1.6× 16 658

Countries citing papers authored by Petros Fessas

Since Specialization
Citations

This map shows the geographic impact of Petros Fessas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petros Fessas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petros Fessas more than expected).

Fields of papers citing papers by Petros Fessas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petros Fessas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petros Fessas. The network helps show where Petros Fessas may publish in the future.

Co-authorship network of co-authors of Petros Fessas

This figure shows the co-authorship network connecting the top 25 collaborators of Petros Fessas. A scholar is included among the top collaborators of Petros Fessas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petros Fessas. Petros Fessas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Hessey, Sonya, Petros Fessas, Simone Zaccaria, Mariam Jamal‐Hanjani, & Charles Swanton. (2023). Insights into the metastatic cascade through research autopsies. Trends in cancer. 9(6). 490–502. 9 indexed citations
3.
Fessas, Petros, Bernhard Scheiner, Antonio D’Alessio, et al.. (2023). PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma. Future Oncology. 19(7). 499–507. 3 indexed citations
4.
Dharmapuri, Sirish, Umut Özbek, Anwaar Saeed, et al.. (2022). Relationship between systemic inflammatory response markers and immune treatment related toxicity (IrAEs) in hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 40(16_suppl). e16204–e16204. 1 indexed citations
5.
Fessas, Petros, Paolo Spina, Renzo Boldorini, et al.. (2021). Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma. Cancers. 13(9). 2137–2137. 12 indexed citations
6.
Pinato, David J., Nadia Guerra, Petros Fessas, et al.. (2020). Immune-based therapies for hepatocellular carcinoma. Oncogene. 39(18). 3620–3637. 146 indexed citations
7.
Wong, Ching Ngar, Petros Fessas, Kathy Dominy, et al.. (2020). Qualification of tumour mutational burden by targeted next‐generation sequencing as a biomarker in hepatocellular carcinoma. Liver International. 41(1). 192–203. 34 indexed citations
8.
Pinato, David J., Petros Fessas, Gonzalo Sapisochín, & Thomas U. Marron. (2020). Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular Carcinoma. Hepatology. 74(1). 483–490. 56 indexed citations
9.
Fessas, Petros, Ahmed O. Kaseb, Yinghong Wang, et al.. (2020). Post-registration experience of nivolumab (nivo) therapy in patients with advanced hepatocellular carcinoma (HCC): An international study.. Journal of Clinical Oncology. 38(15_suppl). e16677–e16677. 1 indexed citations
10.
Ali, Syed O., Petros Fessas, Joshua Kaggie, et al.. (2019). Evaluation of the sensitivity of R1ρ MRI to pH and macromolecular density. Magnetic Resonance Imaging. 58. 156–161. 8 indexed citations
11.
Fessas, Petros, Lucia Possamai, James J. Clark, et al.. (2019). Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms. Immunology. 159(2). 167–177. 73 indexed citations
12.
Fessas, Petros, et al.. (2018). Question 1: Is there a role for the ketogenic diet in refractory status epilepticus?. Archives of Disease in Childhood. 103(10). 994.1–997. 2 indexed citations
13.
Fessas, Petros, Hassal Lee, Shinji Ikemizu, & Tobias Janowitz. (2017). A molecular and preclinical comparison of the PD-1–targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab. Seminars in Oncology. 44(2). 136–140. 183 indexed citations
14.
Tsokos, George C., Michail Papamichail, & Petros Fessas. (1980). A Subpopulation of Lymphocytes with T and B Cell Characteristics. Acta Haematologica. 63(2). 88–93. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Spoto Breakdown of academic impact, for papers by Vito Longo Breakdown of academic impact, for papers by Tongguo Si Breakdown of academic impact, for papers by Claudia Angela Maria Fulgenzi Breakdown of academic impact, for papers by Imane El Dika Breakdown of academic impact, for papers by Antonio Gnoni Breakdown of academic impact, for papers by Giulia Orsi Breakdown of academic impact, for papers by Gataree Ngarmchamnanrith Breakdown of academic impact, for papers by Chuyu Jing Breakdown of academic impact, for papers by Bernadette Reyna Asuncion
Rankless by CCL
2026